Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 7Colonic Neoplasms 3Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Peritoneal Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Neoplasm Metastasis 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Krukenberg Tumor 1Hyperthermia 1Eye Neoplasms 1Endometrial Neoplasms 1Complex Ovarian Cyst 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1

Interventions

apatinib 1Neoadjuvant Therapy 1Laparotomy 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Peritoneal Metastases From Gastric Cancer × Laparotomy × Clear all
NCT03349827 2020-03-24

HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer

Wuhan University

Phase NA Terminated
20 enrolled
Gastrointestinal

Peritoneal Metastases From Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡